| Medical and Health Sciences | Lifetime | 567 | US 304 | 99.97 |
| Surgery | Lifetime | 37 | US 23 | 99.97 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 86 | US 47 | 99.72 |
| Cancer Research | Lifetime | 202 | US 107 | 98.85 |
| Cardiology and Cardiovascular Medicine | Lifetime | 537 | US 290 | 99.15 |
| Genetics | Lifetime | 798 | US 412 | 98.03 |
| Ocean Engineering | Lifetime | 473 | US 162 | 97.68 |
| Applied Mathematics | Lifetime | 784 | US 278 | 90.75 |
| Biochemistry | Lifetime | 713 | US 314 | 87.62 |
| Genetics | 2021-2025 | 227 | US 84 | 94.10 |
| Surgery | 2021-2025 | 671 | US 254 | 94.13 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 438 | US 193 | 94.39 |
| Cancer, Lipids, and Metabolism | Lifetime | 3 | US 2 | 99.96 |
| Lipid metabolism and disorders | Lifetime | 1 | US 1 | 99.93 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 5 | US 2 | 99.95 |
| Cholesterol and Lipid Metabolism | Lifetime | 4 | US 3 | 99.89 |
| Lipoproteins and Cardiovascular Health | Lifetime | 7 | US 4 | 99.96 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 6 | US 4 | 99.85 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 36 | US 22 | 99.55 |
| Drug Transport and Resistance Mechanisms | Lifetime | 199 | US 79 | 98.95 |
| Particle Dynamics in Fluid Flows | Lifetime | 83 | US 40 | 98.89 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 237 | US 110 | 98.82 |
| Lipid metabolism and biosynthesis | Lifetime | 137 | US 69 | 98.26 |
| Gas Dynamics and Kinetic Theory | Lifetime | 149 | US 67 | 97.98 |
| Genetic Associations and Epidemiology | Lifetime | 239 | US 117 | 98.69 |
| Pharmaceutical Economics and Policy | Lifetime | 169 | US 94 | 97.40 |
| Diet, Metabolism, and Disease | Lifetime | 610 | US 222 | 97.18 |
| Cardiovascular Disease and Adiposity | Lifetime | 704 | US 340 | 96.67 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 917 | US 314 | 96.29 |
| Pharmacology and Obesity Treatment | Lifetime | 868 | US 375 | 91.72 |
| Cyclone Separators and Fluid Dynamics | Lifetime | 721 | US 113 | 92.27 |
| Cardiovascular Health and Risk Factors | Lifetime | 899 | US 451 | 90.11 |
| Lipid metabolism and disorders | 2021-2025 | 17 | US 7 | 97.06 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 136 | US 54 | 96.86 |
| Genetic Associations and Epidemiology | 2021-2025 | 204 | US 83 | 95.59 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 253 | US 65 | 93.13 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 230 | US 62 | 94.29 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 841 | US 184 | 76.65 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 786 | US 200 | 73.89 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 282 | US 67 | 73.87 |
